NCT01510561 A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. Status WITHDRAWN Phase PHASE1
NCT01505179 The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction Status COMPLETED Phase NA
NCT01497899 Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults Status COMPLETED Phase PHASE2
NCT01495702 Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients Status COMPLETED Phase PHASE3
NCT01494987 Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01488526 Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus Status COMPLETED Phase PHASE4
NCT01480336 The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot Status COMPLETED Phase NA
NCT01479465 Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma Status TERMINATED Phase PHASE2
NCT01475838 Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients Status COMPLETED Phase PHASE3
NCT01472198 A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01472185 Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01469364 Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) Status COMPLETED Phase PHASE4
NCT01466790 A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients Status COMPLETED Phase PHASE2
NCT01457768 A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response Status COMPLETED Phase N/A
NCT01452308 Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis Status COMPLETED Phase PHASE2
NCT01448616 Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding Status COMPLETED Phase PHASE4